ClinicalTrials.Veeva

Menu

Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease (MiDCR)

N

Nantes University Hospital (NUH)

Status

Terminated

Conditions

Alzheimer Disease
Intestinal Microbiota

Treatments

Procedure: Fecal sample collection

Study type

Interventional

Funder types

Other

Identifiers

NCT03487380
RC17_0162
2017-A02246-47 (Other Identifier)

Details and patient eligibility

About

The objective of the study is to highlight a modification of the composition of the intestinal microbiota associated with the diagnosis of Alzheimer's disease and its most unfavorable form, Rapid Cognitive Decline (DCR). This identification could lead to diagnostic strategies based on the analysis of the intestinal microbiome, and preventive and curative treatments, based on the modulation of intestinal microbiota

Enrollment

86 patients

Sex

All

Ages

70 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

For Alzheimer groups without DCR and Alzheimer with DCR:

  • patients between 70 and 90 years old
  • with mild to moderate Alzheimer's disease (MMSE> 15/30),
  • followed in the CMRR of the University Hospital of Nantes or Angers
  • having given their informed consent

For the control group (non-Alzheimer's)

  • more patients between 70 and 90 years
  • consultant for a subjective memory complaint isolated at the CMRR of Nantes or Angers University Hospital,
  • having given their informed consent

Exclusion criteria

  • Major patients under tutorship, curatorship or safeguard of justice
  • Cognitive disorders possibly related to a metabolic or psychiatric cause
  • History of prescription of antibiotic treatment in the last month
  • History of acute gastrointestinal illness in the last month
  • History of hospitalization for an acute medical pathology or for a surgical procedure in the last month

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

86 participants in 3 patient groups

Alzheimer with rapid DCR
Experimental group
Treatment:
Procedure: Fecal sample collection
Alzheimer without rapid DCR
Experimental group
Treatment:
Procedure: Fecal sample collection
Control
Sham Comparator group
Treatment:
Procedure: Fecal sample collection

Trial contacts and locations

2

Loading...

Central trial contact

Guillaume Chapelet, Dr; Laure de Decker, Pr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems